Investing Profile

Bali Muralidhar

InvestorVC
Managing Partner, Chief Investment Officer at Abingworth
abingworth.com/team/bali-mura...London
Photo of Bali Muralidhar, Managing Partner at Abingworth
Your Intro Paths to Bali Muralidhar

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Networks Bali is a member of
IT CRUX Mobile Apps Solutions Network
397 CONNECTIONS
IT CRUX Mobile Apps Solutions Network
397 CONNECTIONS
IT CRUX Mobile Apps Solutions Network
397 CONNECTIONS
Bain & Company Network
345 CONNECTIONS
Bain Capital Network
276 CONNECTIONS

Find Bali Muralidhar on

cb
Current Investing Position
Abingworth Managing Partner
Investment Range
$15.0M - $30.0M
Sweet Spot
$22.5M
Investments On Record
15
Current Fund Size
$465M

Bali Muralidhar is on these Sector & Stage Rankings

Bali Muralidhar's Investments On Record (12)

CompanyStageDateRound SizeTotal Raised
AdvanCell
Series DJul 2026$320M
Series CFeb 2025$110M
$430M
Co-investors: Jamil Beg (5am Ventures), Christopher Gagliardi (Sanofi Ventures)
Cytospire Therapeutics
Series AMay 2026$83M
$83M
Co-investors: Owen Smith (4BIO Capital)
Allotera Therapeutics
Series CAug 2025$120M
Series BJul 2021$170M
$290M
Co-investors: John McKearn (RiverVest Venture Partners), Niall O’Donnell (RiverVest)
Glycomine
Series CApr 2025$120M
Series BJun 2021$35M
$150M
Co-investors: Dominic Schmidt (Advent Life Sciences), Niall O’Donnell (RiverVest), Jim Trenkle (Sanofi Ventures)
Ascend Gene & Cell Therapies
Series AMar 2023$66M
$66M
Co-investors: Eric Shiozaki (DCVC (Data Collective)), Andrew Kozlov (4BIO Capital), Andrew Sinclair (Abingworth)
Anjarium Biosciences
Series ASep 2021$60M
$60M
CymaBay Therapeutics
Post Ipo DebtAug 2021$100M
$190M
Co-investors: Andrew Schwab (5am Ventures), Tony Evnin (Venrock)
Reneo Pharmaceuticals
Series BDec 2020$95M
$150M
Co-investors: Ed Mathers (New Enterprise Associates (NEA)), Niall O’Donnell (RiverVest)

Bali Muralidhar's Experience

Clinical Fellow IT CRUX Mobile Apps SolutionsPresent
Researcher IT CRUX Mobile Apps SolutionsPresent
Bye-Fellow IT CRUX Mobile Apps SolutionsPresent
Consultant Bain & CompanyPresent
Associate Bain CapitalPresent
Partner MVM PartnersPresent
Partner AbingworthPresent
Managing Partner AbingworthPresent
Managing Partner, Chief Investment Officer AbingworthPresent
Non Executive Director British Business BankPresent
Global Head of Life Sciences AbingworthPresent

Bali Muralidhar's Education

University of Cambridge MA Medical Science
University of Oxford BMBCh Clinical medicine
University of Cambridge PhD Cancer biology

Investors who invest with Bali Muralidhar

Sign in with Google →

Scouts & Angels Affiliated With Bali Muralidhar

Sign in with Google →